STOCK TITAN

Enovis (ENOV) CAO adds 1,250 shares in two open-market buys

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Enovis CORP Chief Administrative Officer Oliver Engert reported buying 1,250 shares of common stock in open-market transactions. He purchased 1,000 shares at a weighted average price of $24.77 on March 3, 2026, and 250 shares at $25.10 on March 4, 2026, bringing his direct holdings to 44,890 shares.

The filing notes that the $24.77 price reflects a weighted average for multiple trades completed between $24.64 and $24.89 per share.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Engert Oliver

(Last) (First) (Middle)
2900 LAKE VISTA DRIVE
SUITE 200

(Street)
LEWISVILLE TX 75067

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Administrative Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 03/03/2026 P 1,000 A $24.77(1) 44,640 D
Common stock, par value $0.001 03/04/2026 P 250 A $25.1 44,890 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $24.64 to $24.89, inclusive. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
/s/ Brian P. Hanigan, attorney-in-fact 03/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Enovis (ENOV) executive Oliver Engert report in this Form 4?

Oliver Engert reported buying 1,250 shares of Enovis common stock in the open market. The purchases occurred over two days and increased his direct ownership stake to 44,890 shares following the last reported transaction.

How many Enovis (ENOV) shares did Oliver Engert buy and at what prices?

He bought 1,000 shares at a weighted average price of $24.77 and 250 shares at $25.10. The weighted price reflects multiple trades executed in a range between $24.64 and $24.89 per share, according to the Form 4 disclosure.

What is Oliver Engert’s role at Enovis (ENOV) and how many shares does he own now?

Oliver Engert is the Chief Administrative Officer of Enovis. After these open-market purchases, he directly owns 44,890 shares of Enovis common stock, as reported in the post-transaction ownership column of the Form 4 filing.

Were the Enovis (ENOV) Form 4 transactions open-market purchases or something else?

Both transactions were open-market purchases coded “P” on the Form 4. The filing describes them as purchases in open-market or private transactions, with the reporting person acquiring additional common stock directly rather than disposing of shares.

What does the weighted average price disclosure mean in the Enovis (ENOV) Form 4?

The Form 4 explains that the $24.77 price is a weighted average across multiple trades between $24.64 and $24.89. The reporting person states he can provide full trade-price details to Enovis or SEC staff upon request, reflecting standard disclosure practice.
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.39B
55.86M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON